Drug Device Combination Products Market Share 2021: Global Trends, Key Players, Industry Analysis Report to 2027
The Drug Device Combination Products Market size is expected to grow at an annual average of 10% during 2021-2027. A drug-device combination product is a medical device that consists of a medical device and an active pharmaceutical ingredient that are physically or chemically joined together as a “monolith”. These products lead to safer and more effective management and treatment of multiple disorders due to their precise drug delivery, topical administration and individual treatment. Featured drug-device combination products include drug-eluting stents, infusion pumps, inhalers, transdermal delivery systems, and prefilled syringes. This technologically advanced product is used to manage and treat a number of chronic conditions such as cancer, diabetes, respiratory problems, cardiovascular disease, wound healing, and more.
The following segmentation are covered in this report:
By End User
- Hospital & clinic
- Ambulatory surgery center (ASC)
- Home care setting
- Other end users
By Wound Type
- Cardiovascular disease
- Diabetes
- Respiratory problem
- Cancer treatment
- Antimicrobial application
- Other applications
Company Profile
- Abbott Laboratories
- Medtronic Plc
- Boston Scientific Corp
- Becton, Dickinson and Company
- Novartis AG
- GlaxoSmithKline plc
- Allergen, Inc.
- Stryker Corporation
- Terumo Corporation
Scope of the report
The research study analyses the Drug Device Combination Products Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent developments
- Market overview and growth analysis
- Import and export overview
- Volume analysis
- Current market trends and future outlook
- Market opportunistic and attractive investment segment
Geographic coverage
- North america market size and/or volume
- Latin america market size and/or volume
- Europe market size and/or volume
- Asia-pacific market size and/or volume
- Rest of the world market size and/or volume
Key Questions Answered by Drug Device Combination Products Market Report
- What was the Drug Device Combination Products Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
- What will be the CAGR of Market during the forecast period (2021-2027)?
- Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
- Which manufacturer/vendor/players in the Drug Device Combination Products Market was the market leader in 2020?
- Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report will be delivered within 48-72 hours after payment confirmation